-

Susan G. Komen and Amgen to Help People Understand and Monitor Breast and Bone Health

Bone Complication Impacts 70% of People Living with Metastatic Breast Cancer

DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, today unveiled a new integrated campaign, in partnership with Amgen, to educate the breast cancer community about the link between breast and bone health, providing useful information for women of all ages and stages of breast cancer.

“Breast cancer treatment can affect bone health, and it is one of main areas where breast cancers spread when they metastasize. Yet no matter your age, health or breast cancer diagnosis, your bone health may also be at risk,” said Paula Schneider, president and CEO of Susan G. Komen and a breast cancer survivor. “Women have long known that it is important to understand what is normal for their breast health and to talk to their doctor if they notice any changes. Women need to include their bones in this moment of vigilance.”

Metastatic breast cancer, also known as stage IV breast cancer, is when the breast cancer spreads beyond the breast and nearby lymph nodes to other parts of the body, often the bones. When breast cancer cells spread to the bones, lesions can occur that cause the bones to break easily and may result in spinal cord compression. Research shows that 70 percent of women with bone metastasis will have a skeletal related event within two years of diagnoses. All of these skeletal complications can lead to chronic pain and the loss of mobility.

Through a mixture of facts and personal storytelling, the integrated campaign will drive people to komen.org/breast-and-bone-health, where women will be provided useful information about their breast and bone health, including:

  • Questions to ask your doctor about metastatic breast cancer and bone protection
  • How to protect bones from fractures and other problems, including through diet
  • What treatments may negatively impact bone health
  • What drugs are available to improve bone density

Amgen also provides additional information for people living with metastatic breast cancer on its website – Let’s Talk Bone Mets.

Together, the two organizations seek to inspire people to learn more about their breast and bone health and become empowered to monitor their health and have constructive conversations with their health care teams.

About Susan G. Komen®

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit www.komen.org or call 1-877 GO KOMEN. Connect with us on social media at www.komen.org/contact-us/follow-us/.

Contacts

Sean Tuffnell
Susan G. Komen®
972-855-4382
press@komen.org

Susan G. Komen


Release Summary
Susan G. Komen and Amgen unveiled a new campaign to educate the breast cancer community about the link between breast and bone health.
Release Versions

Contacts

Sean Tuffnell
Susan G. Komen®
972-855-4382
press@komen.org

Social Media Profiles
More News From Susan G. Komen

Susan G. Komen® Awards $15.4 Million In Research Grants to Accelerate Breakthroughs in Breast Cancer Care

DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, today awarded $15.4 million in grants to cutting-edge breast cancer researchers who are bringing us closer to the cures for all breast cancers. The funded projects span some of the most promising areas of research, including the use of artificial intelligence for better health outcomes and vaccine-based approaches targeting the most aggressive and deadliest forms of breast cancer. In total, 35 researchers...

Susan G. Komen® Advocates for Access to Breast Care Imaging as Voter Support Grows

WASHINGTON--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, urged lawmakers on Capitol Hill to put their full support behind pending legislation that would expand access to early detection and require insurance companies to fully cover the cost of all recommended breast imaging, not just routine screening mammograms. The call-to-action comes amid a new national poll showing 90% of voters support proposals that would eliminate out-of-pocket costs for imaging and...

Pennsylvania Community Unites at 2026 Susan G. Komen® MORE THAN PINK Walks

PHILADELPHIA--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, will bring together breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at two Pennsylvania MORE THAN PINK Walks in May. Our community will come together to make sure no one faces breast cancer alone and help advance Komen’s mission to save lives through research, public policy, education and care. This year, Komen aims to raise $350,000 at the Philadelphia MORE T...
Back to Newsroom